Condition
Spindle Cell Sarcoma of Bone
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
5 treatments under study, led by Doxorubicincisplatinifosfamide
Research Leaders
5 sponsors active, led by Cooperative Osteosarcoma Study Group
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Doxorubicincisplatinifosfamide1
- Methotrexate1
- Glucarpidase1
- Doxorubicincisplatinifosfamidemethotrexate1
- Leucovorin1
Active Sponsors
- Cooperative Osteosarcoma Study Group1
- Scandinavian Sarcoma Group1
- Italian Sarcoma Group1
- University College, London1
- Richard Scowcroft Foundation1
Top Investigators
Italian Sarcoma Group
University College London Hospitals
Related Conditions
- Osteosarcoma2